WO2012059585A1 - Process for the preparation of substituted n-(benzyl)cyclopropanamines by imine hydrogenation - Google Patents

Process for the preparation of substituted n-(benzyl)cyclopropanamines by imine hydrogenation Download PDF

Info

Publication number
WO2012059585A1
WO2012059585A1 PCT/EP2011/069426 EP2011069426W WO2012059585A1 WO 2012059585 A1 WO2012059585 A1 WO 2012059585A1 EP 2011069426 W EP2011069426 W EP 2011069426W WO 2012059585 A1 WO2012059585 A1 WO 2012059585A1
Authority
WO
WIPO (PCT)
Prior art keywords
alkyl
different halogen
halogen atoms
carbonyl
alkoxy
Prior art date
Application number
PCT/EP2011/069426
Other languages
French (fr)
Inventor
Norbert Lui
Wahed Ahmed Moradi
Thomas Norbert MÜLLER
Original Assignee
Bayer Cropscience Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP2013537149A priority Critical patent/JP2014503481A/en
Priority to KR1020137014336A priority patent/KR101874659B1/en
Priority to MX2015006719A priority patent/MX364906B/en
Priority to US13/883,241 priority patent/US9260378B2/en
Priority to MX2013004881A priority patent/MX2013004881A/en
Priority to EP11778894.3A priority patent/EP2635551B1/en
Application filed by Bayer Cropscience Ag filed Critical Bayer Cropscience Ag
Priority to ES11778894.3T priority patent/ES2680546T3/en
Priority to DK11778894.3T priority patent/DK2635551T3/en
Priority to CN201180053177.2A priority patent/CN103402970B/en
Priority to BR112013010990-4A priority patent/BR112013010990B1/en
Publication of WO2012059585A1 publication Critical patent/WO2012059585A1/en
Priority to IL226132A priority patent/IL226132B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/44—Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of carboxylic acids or esters thereof in presence of ammonia or amines, or by reduction of nitriles, carboxylic acid amides, imines or imino-ethers
    • C07C209/52—Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of carboxylic acids or esters thereof in presence of ammonia or amines, or by reduction of nitriles, carboxylic acid amides, imines or imino-ethers by reduction of imines or imino-ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/34—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
    • C07C211/35—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing only non-condensed rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/02—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/58—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms with amino groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04—Formation of amino groups in compounds containing carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
    • C07C251/24—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Definitions

  • the present invention relates to a process for the preparation of substituted N-(benzyl)cyclopropanamines of the general formula (II) starting from N-[(aryl)methylene]cyclopropanamine derivatives.
  • the present invention further provides the N-[(aryl)methylene]cyclopropanamine derivatives used as starting compounds in this process according to the invention and also their use for the preparation of substituted N-(benzyl)cyclopropanamines.
  • N-(benzyl)cyclopropanamines are important intermediates for the manufacture of agrochemical active ingredients.
  • Correspondingly substituted N-(benzyl)cyclopropanamines are described, for example, in the synthesis of fungicidally effective pyrazolecarboxamides (cf. e.g.. WO 2007/087906, PCT/EP2010/056521). It is known that N- (phenylmethylene)cyclopropanamine can be reduced with sodium cyanoborohydride to give N-benzyl- cyclopropanamine (see J. Lab. Comp. Radiop arm. 1981, 18, 781-90 and J. Org. C em. 2000, 65, 96-103).
  • a disadvantage of this process is high costs of sodium cyanoborohydride.
  • sodium triacetoxyboro- hydride is used instead of sodium cyanoborohydride.
  • Synthetic Commun. 2003, 33, 3419-3425 only borohydride in methanol is used.
  • the costs are too high.
  • a further process the alkylation of cyclopropylamine with benzyl bromide, is described in Bioorg. Med. Chem. 2006, 14, 8506-8518. Here, the yield following complex chromatography is only 48%. In the case alkylation with benzyl bromide, the possible polyalkylation also takes place.
  • Tetrahedron 2008, 64, 11783-11788 describes the preparation of N-monosubstituted benzylamines with hydrogen and palladium on carbon in chloroform. This gives the hydrochloride.
  • a disadvantage of this process is the use of toxic chloroform and corrosion problems on account of the acidic hydrogenation.
  • the hydrogenolysis of cyclopropyl groups to the corresponding n-propyl or isopropyl derivatives in the presence of hydrogenation catalysts even under mild conditions is generally known and adequately described (cf.
  • the object of the present invention is to provide an alternative process for the preparation of substituted N-(benzyl)cyclopropanamines which can preferably be carried out easily and cost- effectively.
  • the substituted N-(benzyl)cyclopropanamines obtainable using this desired process should preferably be obtained with high yield and high purity.
  • the desired process should allow the desired tar- get compounds to be obtained without the need for complex purification methods.
  • This object is achieved by a novel process for the preparation of substituted N-(benzyl)cyclopropanamines.
  • Z is hydrogen, Ci-Cg-alkyl, Ci-C 4 -haloalkyl or C 3 -C 7 -cycloalkyl,
  • X is halogen, cyano, hydroxyl, Ci-Cg-alkyl, Ci-Cg-haloalkyl having up to 9 identical or different halogen atoms, Ci-Cg-alkylamino, di(Ci-Cg-alkyl)amino, Ci-Cg-alkoxy, Ci-Cg-haloalkoxy having up to 9 identical or different halogen atoms, Ci-Cg-alkoxy-Ci-Cg-alkyl; Ci-Cg-alkylsulphanyl, Ci-Cg-haloalkylsulphanyl having up to 9 identical or different halogen atoms, C 3 -C 7 -cycloalkyl, (C 3 -C7-cycloalkyl)-Ci-Cg-alkyl, C 3 -C 7 - halocycloalkyl having up to 9 identical or different halogen atom, formyl, formyloxy, formylamino, carboxy,
  • substituents X can form a 5- or 6-membered ring, which may be saturated or unsaturated and optionally also comprises heteroatoms,
  • n 1, 2, 3, 4 or 5
  • Z is preferably hydrogen, methyl, ethyl, propyl or isopropyl.
  • X is preferably halogen, Ci-Cg-alkyl, Ci-Cg-haloalkyl having up to 9 identical or different halogen atoms,
  • Ci-Cg-alkoxy Ci-Cg-haloalkoxy having up to 9 identical or different halogen atoms, carboxy, C 3 -C 7 - cycloalkyl or tri(Ci-Cg-alkyl)silyl.
  • two substituents X preferably form a 5- or 6-membered ring, as a result of which a bicycle selected from 1,3-benzodioxolyl, 1,2,3,4-tetrahydroquinoxalinyl, 3,4-dihydro-2H-l,4-benzoxazinyl, 1,4- benzodioxanyl, indanyl, 2,3-dihydrobenzofuranyl or indolinyl is formed,
  • n is preferably 1. 2 or 3.
  • Z is particularly preferably hydrogen, methyl.
  • X is particularly preferably fluorine, chlorine, methyl, ethyl, propyl, isopropyl, tert-butyl, trifluoromethyl, difluoromethyl, methoxy, trifluoromethoxy, difluoromethoxy, trimethylsilyl, carboxy.
  • n is particularly preferably 1 or 2.
  • Z is very particularly preferably hydrogen.
  • X is very particularly preferably fluorine, chlorine, methyl, methoxy, isopropyl, tert-butyl, trifluoromethyl, trifluoromethoxy, trimethylsilyl, carboxy.
  • n is very particularly preferably 1.
  • the desired substituted N-(benzyl)cyclopropanamines of the general formula (II) are prepared by a catalytic hydrogenation of the corresponding N-[(aryl) methylene] cyclo- propanamine derivatives of the general formula (I).
  • the desired substituted N-(benzyl)cyclopropanamines of the general formula (II) are obtained under the preferred reaction conditions according to the invention and specified in more detail below, with good yields in high purity, the process according to the invention thus overcoming the disadvantages specified above.
  • the desired compounds are obtained here in a purity which generally renders extensive work-up of the direct reaction product unnecessary.
  • alkyl either on its own or in combination with further terms such as, for example, haloalkyl, is understood as meaning a radical of a saturated, aliphatic hydrocarbon group having 1 to 8 carbon atoms, which may be branched or unbranched.
  • Ci-Cg-alkyl radicals are methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, neopentyl, tert-pentyl, 1-methylbutyl, 2-methylbutyl, 1-ethylpropyl, 1,2-dimethylpropyl, n-hexyl n-heptyl and n-octyl. From these alkyl radicals, Ci-C 6 -alkyl radicals are particularly preferred. Ci-C 4 -alkyl radicals are especially preferred.
  • aryl is understood as meaning an aromatic radical having 6 to 14 carbon atoms, preferably phenyl.
  • halogen substituted by halogen are understood as meaning, for example, haloalkyl, radicals halogenated one or more times up to the maximum possible number of substitu- ents.
  • the halogen atoms may be identical or different.
  • Halogen here stands for fluorine, chlorine, bromine or iodine, in particular for fluorine, chlorine or bromine.
  • alkoxy either on its own or in combination with further terms such as, for example, haloalkoxy, is in the present case understood as meaning a radical O-alkyl, the term “alkyl” having the meaning above.
  • Optionally substituted radicals may be mono- or polysubstituted, where, in the case of a polysubstitution, the substituents may be identical or different.
  • the conversion of the N-[(aryl)methylene]cyclopropanamine derivatives of the general formula (I) to the corresponding amines of the general formula (II) is carried out by a catalytic hydrogenation [Process (A)].
  • the catalyst which may be used for the catalytic hydrogenation for reducing the compound of the general formula (I) is any desired hydrogenation catalyst.
  • Suitable catalysts optionally comprise one or more metals of groups 8 - 10 of the Periodic Table of the Elements on an arbitrary customarily inorganic support. Of suitability are, for example, precious metal catalysts, such as ruthenium catalysts, palladium catalysts, platinum catalysts and rhodium catalysts, Raney nickel catalysts and Raney cobalt and Lindlar catalysts.
  • the corresponding catalysts can be used in supported form, for example on carbon (carbon or activated carbon). Aluminium oxide, silicon dioxide, zirconium dioxide, calcium carbonate or titanium dioxide. Corresponding catalysts are known per se to the person skilled in the art. Particular preference is given to palladium catalysts. The catalysts can be used either in their damp form or dry form. The catalyst used is preferably reused for several reactions.
  • the catalyst is used in a concentration of from about 0.01 to abut 30% by weight, based on the imine of the formula (I) used.
  • the catalyst is used in a concentration o from about 0.01 to about 5% by weight, particularly preferably from about 0.1 to about 2.0% by weight.
  • the catalytic hydrogenation can be carried out under superatmospheric pressure in an autoclave or at atmospheric pressure in a hydrogen gas atmosphere.
  • the hydrogen gas atmosphere can additionally also comprise inert gases, for example argon or nitrogen.
  • the catalytic hydrogenation is carried out preferably at a temperature of form 10 to 200°C, particularly preferably at 10 to 150°C, very particularly preferably at 10 to 60°C.
  • the hydrogen pressure is usually 0.1 to 50 bar, preferably 0.1 to 30 bar, particularly preferably 1 to 6 bar.
  • Solvents are advantageously used in an amount such that the reaction mixture remains readily stirrable throughout the entire hydrogenation process.
  • Suitable solvents for carrying out the process according to the invention are all organic solvents that are inert under the reaction conditions, the type of solvent used depending on the way in which the reduction is carried out.
  • alcohols such as methanol, ethanol, isopropanol, butanol
  • ethers such as ethyl propyl ether, methyl tert-butyl ether, «-butyl ether, anisole, phenetol, cyclohexyl methyl ether, dimethyl ether, diethyl ether, dimethyl glycol diphenyl ether, dipropyl ether, diisopropyl ether, di- «-butyl ether, diisobutyl ether, diisoamyl ether, ethylene glycol dimethyl ether, isopropyl ethyl ether, tetrahydrofuran, methyl tetrahydro- furan, dioxane, dichlorodiethyl ether and polyethers of ethylene oxide and/or propylene oxide; amines such as trimethyl-, triethyl-, tripropyl-, tributylamine
  • reaction according to the invention as in process (A) can also be carried out without a diluent for N-[(aryl)methylene]cyclopropylamine derivatives of the formula (I) that are present in liquid form.
  • solvent amounts used when carrying out the process (A) according to the invention can be varied within a wide range.
  • solvent amounts in the range from 1 times to 50 times the amount of solvent, particularly preferably from 2 times to 40 times the amount of solvent, in particular from 2 times to 30 times the amount of solvent, in each case based on the N-[(aryl)methylene]cyclopropanamine derivative of the general formula (I) used, are used.
  • the present invention also relates to the use of the compounds of the formula (I) for the preparation of compounds of the general formula (II), as is disclosed in the process described above.
  • the present invention also provides a process (B) for the preparation of the N-[(aryl)methylene]cyclopropanamine derivatives of the general formula (I)
  • an acid can optionally be added as catalyst.
  • examples thereof are acetic acid, p-toluolenesulphonic acid, trifluoroacetic acid.
  • Acetic acid is preferably used.
  • Acidic salts can also be used, e.g. KHS0 4 or NaHS0 4 .
  • corresponding catalysts are used, then their amount can be from 0.01 to 10 percent by weight, based on the cyclopropylamine used.
  • process (B) can also be carried out such that the water which is formed during the reaction between amine and carbonyl compound of the formula (III) by condensation is removed from the reaction mixture.
  • water-binding agents for example sodium sulphate, magnesium sulphate or molecular sieve, or by using a device for separating off water.
  • the hydrogenation can, however, also be carried out without removal of the water.
  • Process (B) can generally be carried out under reduced pressure, at atmospheric pressure or under superatmos- pheric pressure.
  • the temperatures used can likewise vary, depending on the substrates used, and are easy for the person skilled in the art to ascertain through routine experiments.
  • the reaction for the preparation of the compounds of the general formula (I) can be carried out at a temperature of -20°C to 200°C, preferably 10 to 100°C. Particular preference is given to carrying out the reaction at atmospheric pressure and temperatures of 10 to 100°C.
  • process (B) can also be carried out in the presence of solvents (diluents). The solvents are also used in this process step preferably in an amount such that the reaction mixture remains readily stirrable throughout the entire process.
  • Suitable solvents for carrying out the process according to the invention for the preparation of the imines of the general formula (I) are all organic solvents that are inert under the reaction conditions. Examples are: alcohols such as methanol, ethanol, isopropanol, butanol; ethers, such as ethyl propyl ether, methyl tert-butyl ether, «-butyl ether, anisole, phenetol, cyclohexyl methyl ether, dimethyl ether, diethyl ether, dimethyl glycol diphenyl ether, dipropyl ether, diisopropyl ether, di- «-butyl ether, diisobutyl ether, diisoamyl ether, ethylene glycol dimethyl ether, isopropyl ethyl ether, tetrahydrofuran, dioxane, dichlorodiethyl ether and polyethers of ethylene oxide and/or propylene oxide
  • reaction between amine and the carbonyl compound of the formula (III) can also take place without a diluent.
  • process (B) is carried out in a solvent
  • the solvent can be removed by distillation after the end of the reaction. This can take place under atmospheric pressure or reduced pressure at room temperature or elevated tempera- tures.
  • the mixture can also be transferred directly to the hydrogenation, which is advantageous particularly from the point of view of economic considerations.
  • a work-up of the imine of the formula (I) is then dispensed with.
  • the present invention further provides the N-[(aryl)methylene]cyclopropanamine derivative of the general formula (I)
  • the reaction was carried out on a 0.072 molar scale. The hydrogen absorption was complete after five hours. The desired product was obtained in 80.4% yield.

Abstract

The present invention relates to a process for the preparation of substituted N-(benzyl)cyclopropanamines of the general formula (II) starting from N-[(aryl)methylene]cyclopropanamine derivatives. The present invention further provides the N-[(aryl)methylene]cyclopropanamine derivatives used as starting compounds in this process according to the invention, and their use for the preparation of substituted N-(benzyl)cyclopropanamines.

Description

Process for the preparation of substituted N-(benzyl)cvclopropanamines by imine hydrogenation
The present invention relates to a process for the preparation of substituted N-(benzyl)cyclopropanamines of the general formula (II) starting from N-[(aryl)methylene]cyclopropanamine derivatives. The present invention further provides the N-[(aryl)methylene]cyclopropanamine derivatives used as starting compounds in this process according to the invention and also their use for the preparation of substituted N-(benzyl)cyclopropanamines.
Substituted N-(benzyl)cyclopropanamines are important intermediates for the manufacture of agrochemical active ingredients. Correspondingly substituted N-(benzyl)cyclopropanamines are described, for example, in the synthesis of fungicidally effective pyrazolecarboxamides (cf. e.g.. WO 2007/087906, PCT/EP2010/056521). It is known that N- (phenylmethylene)cyclopropanamine can be reduced with sodium cyanoborohydride to give N-benzyl- cyclopropanamine (see J. Lab. Comp. Radiop arm. 1981, 18, 781-90 and J. Org. C em. 2000, 65, 96-103). A disadvantage of this process is high costs of sodium cyanoborohydride. In WO 2006/066896, sodium triacetoxyboro- hydride is used instead of sodium cyanoborohydride. In Synthetic Commun. 2003, 33, 3419-3425, only borohydride in methanol is used. Here too, the costs are too high. A further process, the alkylation of cyclopropylamine with benzyl bromide, is described in Bioorg. Med. Chem. 2006, 14, 8506-8518. Here, the yield following complex chromatography is only 48%. In the case alkylation with benzyl bromide, the possible polyalkylation also takes place. Tetrahedron 2008, 64, 11783-11788 describes the preparation of N-monosubstituted benzylamines with hydrogen and palladium on carbon in chloroform. This gives the hydrochloride. A disadvantage of this process is the use of toxic chloroform and corrosion problems on account of the acidic hydrogenation. The hydrogenolysis of cyclopropyl groups to the corresponding n-propyl or isopropyl derivatives in the presence of hydrogenation catalysts even under mild conditions is generally known and adequately described (cf. Rylander "Catalytic Hydrogenation in Organic Syntheses", pages 251 to 259, Academic Press, New York, 1979 and Nishimura "Handbook of Heterogeneous Catalytic Hydrogenation for Organic Synthesis", pages 640 to 647, John Wiley & Sons, New York, 2001). A particular example of undesired hydrogenolysis of a cyclopropyl ring in the presence of palladium on carbon at a hydrogen pressure of 1 bar and room temperature is described in Chem. Eur. J. 1997, 3, 1370-1374.
Proceeding from this prior art, the object of the present invention is to provide an alternative process for the preparation of substituted N-(benzyl)cyclopropanamines which can preferably be carried out easily and cost- effectively. The substituted N-(benzyl)cyclopropanamines obtainable using this desired process should preferably be obtained with high yield and high purity. In particular, the desired process should allow the desired tar- get compounds to be obtained without the need for complex purification methods.
This object is achieved by a novel process for the preparation of substituted N-(benzyl)cyclopropanamines.
The process (A) according to the invention is characterized in that N-[(aryl)methylene]cyclopropanamine derivatives of the general formula (I)
Figure imgf000003_0001
in which
Z is hydrogen, Ci-Cg-alkyl, Ci-C4-haloalkyl or C3-C7-cycloalkyl,
X is halogen, cyano, hydroxyl, Ci-Cg-alkyl, Ci-Cg-haloalkyl having up to 9 identical or different halogen atoms, Ci-Cg-alkylamino, di(Ci-Cg-alkyl)amino, Ci-Cg-alkoxy, Ci-Cg-haloalkoxy having up to 9 identical or different halogen atoms, Ci-Cg-alkoxy-Ci-Cg-alkyl; Ci-Cg-alkylsulphanyl, Ci-Cg-haloalkylsulphanyl having up to 9 identical or different halogen atoms, C3-C7-cycloalkyl, (C3-C7-cycloalkyl)-Ci-Cg-alkyl, C3-C7- halocycloalkyl having up to 9 identical or different halogen atom, formyl, formyloxy, formylamino, carboxy, carbamoyl, N-hydroxycarbamoyl, carbamates, (Ci-Cg-alkyl)carbonyl, (Ci-Cg-haloalkyl)carbonyl having up to 9 identical or different halogen atoms, Ci-Cg-alkylcarbamoyl, di(Ci-Cg-alkyl)carbamoyl, N-(Ci-C8-alkyl- oxy)carbamoyl, (Ci-Cg-alkoxy)carbamoyl, N-Ci-Cg-alkyl-(Ci-C8-alkoxy)carbamoyl, (Ci-Cg-alkoxy)- carbonyl, (Ci-Cg-haloalkoxy)carbonyl having up to 9 identical or different halogen atoms, (Ci-C8- akylamino)carbonyl, di(Ci-Cg-alkylamino)carbonyl, (Ci-Cg-alkyl)carbonyloxy, (Ci-Cg-haloalkyl)carbonyl- oxy having up to 9 identical or different halogen atoms, (Ci-Cg-alkyl)carbonylamino, (Ci-Cg-haloalkyl)- carbonylamino having up to 9 identical or different halogen atoms, (Ci-Cg-alkylamino)carbonyloxy, di-(Ci- Cg-alkylamino)carbonyloxy, (Ci-Cg-alkyloxy)carbonyloxy, Ci-Cg-alkylsulphenyl, Ci-Cg-haloalkylsulphenyl having up to 9 identical or different halogen atoms, Ci-Cg-alkylsulphinyl, Ci-Cg-haloalkylsulphinyl having up to 9 identical or different halogen atoms, Ci-Cg-alkylsulphonyl, Ci-Cg-haloalkylsulphonyl having up to 9 identical or different halogen atoms, tri(Ci-Cg-alkyl)silyl, tri(Ci-Cg-alkyl)silyl-Ci-Cg-alkyl,
moreover two substituents X can form a 5- or 6-membered ring, which may be saturated or unsaturated and optionally also comprises heteroatoms,
n is 1, 2, 3, 4 or 5,
are catalytically propanamines of the general formula (II)
Figure imgf000003_0002
in which Z, X und n have the meanings given above.
Preferred, particularly preferred and very particularly preferred meanings of the radicals Z and X and also of index n listed in the general formulae (I) and (II) mentioned above are explained below. These preferred, particularly preferred and very particularly preferred meanings apply equally to all intermediates and end products which are mentioned in this description.
Z is preferably hydrogen, methyl, ethyl, propyl or isopropyl. X is preferably halogen, Ci-Cg-alkyl, Ci-Cg-haloalkyl having up to 9 identical or different halogen atoms,
Ci-Cg-alkoxy, Ci-Cg-haloalkoxy having up to 9 identical or different halogen atoms, carboxy, C3-C7- cycloalkyl or tri(Ci-Cg-alkyl)silyl.
Moreover, two substituents X preferably form a 5- or 6-membered ring, as a result of which a bicycle selected from 1,3-benzodioxolyl, 1,2,3,4-tetrahydroquinoxalinyl, 3,4-dihydro-2H-l,4-benzoxazinyl, 1,4- benzodioxanyl, indanyl, 2,3-dihydrobenzofuranyl or indolinyl is formed,
n is preferably 1. 2 or 3.
Z is particularly preferably hydrogen, methyl.
X is particularly preferably fluorine, chlorine, methyl, ethyl, propyl, isopropyl, tert-butyl, trifluoromethyl, difluoromethyl, methoxy, trifluoromethoxy, difluoromethoxy, trimethylsilyl, carboxy.
n is particularly preferably 1 or 2.
Z is very particularly preferably hydrogen.
X is very particularly preferably fluorine, chlorine, methyl, methoxy, isopropyl, tert-butyl, trifluoromethyl, trifluoromethoxy, trimethylsilyl, carboxy.
n is very particularly preferably 1.
According to the invention, it is thus intended that the desired substituted N-(benzyl)cyclopropanamines of the general formula (II) are prepared by a catalytic hydrogenation of the corresponding N-[(aryl) methylene] cyclo- propanamine derivatives of the general formula (I). The desired substituted N-(benzyl)cyclopropanamines of the general formula (II) are obtained under the preferred reaction conditions according to the invention and specified in more detail below, with good yields in high purity, the process according to the invention thus overcoming the disadvantages specified above. The desired compounds are obtained here in a purity which generally renders extensive work-up of the direct reaction product unnecessary.
Within the context of the present invention, the term "alkyl", either on its own or in combination with further terms such as, for example, haloalkyl, is understood as meaning a radical of a saturated, aliphatic hydrocarbon group having 1 to 8 carbon atoms, which may be branched or unbranched. Examples of Ci-Cg-alkyl radicals are methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, neopentyl, tert-pentyl, 1-methylbutyl, 2-methylbutyl, 1-ethylpropyl, 1,2-dimethylpropyl, n-hexyl n-heptyl and n-octyl. From these alkyl radicals, Ci-C6-alkyl radicals are particularly preferred. Ci-C4-alkyl radicals are especially preferred.
According to the invention, the term "aryl" is understood as meaning an aromatic radical having 6 to 14 carbon atoms, preferably phenyl.
Within the context of the present invention, "radicals substituted by halogen" are understood as meaning, for example, haloalkyl, radicals halogenated one or more times up to the maximum possible number of substitu- ents. In the event of polyhalogenation, the halogen atoms may be identical or different. Halogen here stands for fluorine, chlorine, bromine or iodine, in particular for fluorine, chlorine or bromine.
The term "alkoxy", either on its own or in combination with further terms such as, for example, haloalkoxy, is in the present case understood as meaning a radical O-alkyl, the term "alkyl" having the meaning above. Optionally substituted radicals may be mono- or polysubstituted, where, in the case of a polysubstitution, the substituents may be identical or different.
The conversion of the N-[(aryl)methylene]cyclopropanamine derivatives of the general formula (I) to the corresponding amines of the general formula (II) is carried out by a catalytic hydrogenation [Process (A)]. The catalyst which may be used for the catalytic hydrogenation for reducing the compound of the general formula (I) is any desired hydrogenation catalyst. Suitable catalysts optionally comprise one or more metals of groups 8 - 10 of the Periodic Table of the Elements on an arbitrary customarily inorganic support. Of suitability are, for example, precious metal catalysts, such as ruthenium catalysts, palladium catalysts, platinum catalysts and rhodium catalysts, Raney nickel catalysts and Raney cobalt and Lindlar catalysts. However, besides these heterogeneous catalysts, hydrogenations can also be carried out over homogeneous catalysts, for example over the Wilkinson catalyst. The corresponding catalysts can be used in supported form, for example on carbon (carbon or activated carbon). Aluminium oxide, silicon dioxide, zirconium dioxide, calcium carbonate or titanium dioxide. Corresponding catalysts are known per se to the person skilled in the art. Particular preference is given to palladium catalysts. The catalysts can be used either in their damp form or dry form. The catalyst used is preferably reused for several reactions. In the process (A) according to the invention, the catalyst is used in a concentration of from about 0.01 to abut 30% by weight, based on the imine of the formula (I) used. Preferably, the catalyst is used in a concentration o from about 0.01 to about 5% by weight, particularly preferably from about 0.1 to about 2.0% by weight.
The catalytic hydrogenation can be carried out under superatmospheric pressure in an autoclave or at atmospheric pressure in a hydrogen gas atmosphere. The hydrogen gas atmosphere can additionally also comprise inert gases, for example argon or nitrogen. The catalytic hydrogenation is carried out preferably at a temperature of form 10 to 200°C, particularly preferably at 10 to 150°C, very particularly preferably at 10 to 60°C. The hydrogen pressure is usually 0.1 to 50 bar, preferably 0.1 to 30 bar, particularly preferably 1 to 6 bar.
Further reagents used for the hydrogenation of imines and hydrogenation conditions are described in the publications by Harada, in Patai, "The Chemistry of the Carbon-Nitrogen Double Bond", pages 276 to 293; by Ni- shimura, "Handbook of Heterogeneous Catalytic Hydrogenation for Organic Synthesis2, pages 226 to 250, John Wiley and Sons, New York, 2001 and by Rylander, "Catalytic Hydrogenation over Platinum Metals", pages 291 to 303, Academic Press, New York, 1967. In general, it is advantageous to carry out the process (A) according to the invention for the hydrogenation of the imines in the presence of solvents (diluents). Solvents are advantageously used in an amount such that the reaction mixture remains readily stirrable throughout the entire hydrogenation process. Suitable solvents for carrying out the process according to the invention are all organic solvents that are inert under the reaction conditions, the type of solvent used depending on the way in which the reduction is carried out.
Examples to be mentioned are alcohols such as methanol, ethanol, isopropanol, butanol; ethers, such as ethyl propyl ether, methyl tert-butyl ether, «-butyl ether, anisole, phenetol, cyclohexyl methyl ether, dimethyl ether, diethyl ether, dimethyl glycol diphenyl ether, dipropyl ether, diisopropyl ether, di-«-butyl ether, diisobutyl ether, diisoamyl ether, ethylene glycol dimethyl ether, isopropyl ethyl ether, tetrahydrofuran, methyl tetrahydro- furan, dioxane, dichlorodiethyl ether and polyethers of ethylene oxide and/or propylene oxide; amines such as trimethyl-, triethyl-, tripropyl-, tributylamine, N-methylmorpholine, pyridine, alkylated pyridines and tetrame- thylenediamine; aliphatic, cycloaliphatic or aromatic hydrocarbons, such as pentane, n-hexane, n-heptane, n- octane, nonane and technical-grade hydrocarbons which may be substituted by fluorine and chlorine atoms, such as dichloromethane, trichloromethane, tetrachloromethane, fluorobenzene, chlorobenzene or dichloroben- zene; for example so-called white spirits with components having boiling points in the range for example from 40°C to 250°C, cymene, benzine fractions within a boiling interval from 70°C tol90°C, cyclohexane, methyl- cyclohexane, petroleum ether, ligroin, octane, benzene, toluene, chlorobenzene, bromobenzene, nitrobenzene, xylene; esters such as methyl, ethyl, butyl, isobutyl acetate, and also dimethyl, dibutyl, ethylene carbonate; and aliphatic alcohols, such as methanol, ethanol, n-propanol and isopropanol and n-butanol. Of the aforementioned solvents, preference is given to alcohols, in particular methanol and ethanol, specifically methanol.
The reaction according to the invention as in process (A) can also be carried out without a diluent for N-[(aryl)methylene]cyclopropylamine derivatives of the formula (I) that are present in liquid form.
The amounts of solvents used when carrying out the process (A) according to the invention can be varied within a wide range. In general, solvent amounts in the range from 1 times to 50 times the amount of solvent, particularly preferably from 2 times to 40 times the amount of solvent, in particular from 2 times to 30 times the amount of solvent, in each case based on the N-[(aryl)methylene]cyclopropanamine derivative of the general formula (I) used, are used.
It was surprising to observe that under the particularly preferred reaction conditions of the process according to the invention, a hydrogenolysis of the cyclopropyl substituent is observed only to a very slight extent.
Work-up (purification) and isolation of the hydrogenated imines can take place, for example, by crystallization and/or distillation. Moreover, the present invention also relates to the use of the compounds of the formula (I) for the preparation of compounds of the general formula (II), as is disclosed in the process described above.
The present invention also provides a process (B) for the preparation of the N-[(aryl)methylene]cyclopropanamine derivatives of the general formula (I)
Figure imgf000007_0001
in which Z, X and n have the meanings given above,
characterized in that cyclopropylamine is condensed with carbonyl compounds of the general formula (III)
Figure imgf000007_0002
in which Z, X und n have the meanings given above.
The carbonyl compounds of the formula (III) required as starting materials for this process (B) are commercially available or can be prepared by processes known in the literature.
When carrying out process (B), an acid can optionally be added as catalyst. Examples thereof are acetic acid, p-toluolenesulphonic acid, trifluoroacetic acid. Acetic acid is preferably used. Acidic salts can also be used, e.g. KHS04 or NaHS04.
If corresponding catalysts are used, then their amount can be from 0.01 to 10 percent by weight, based on the cyclopropylamine used.
Moreover, process (B) can also be carried out such that the water which is formed during the reaction between amine and carbonyl compound of the formula (III) by condensation is removed from the reaction mixture. This is possible, for example, by using water-binding agents, for example sodium sulphate, magnesium sulphate or molecular sieve, or by using a device for separating off water. The hydrogenation can, however, also be carried out without removal of the water.
Process (B) can generally be carried out under reduced pressure, at atmospheric pressure or under superatmos- pheric pressure. The temperatures used can likewise vary, depending on the substrates used, and are easy for the person skilled in the art to ascertain through routine experiments. For example, the reaction for the preparation of the compounds of the general formula (I) can be carried out at a temperature of -20°C to 200°C, preferably 10 to 100°C. Particular preference is given to carrying out the reaction at atmospheric pressure and temperatures of 10 to 100°C. Moreover, process (B) can also be carried out in the presence of solvents (diluents). The solvents are also used in this process step preferably in an amount such that the reaction mixture remains readily stirrable throughout the entire process. Suitable solvents for carrying out the process according to the invention for the preparation of the imines of the general formula (I) are all organic solvents that are inert under the reaction conditions. Examples are: alcohols such as methanol, ethanol, isopropanol, butanol; ethers, such as ethyl propyl ether, methyl tert-butyl ether, «-butyl ether, anisole, phenetol, cyclohexyl methyl ether, dimethyl ether, diethyl ether, dimethyl glycol diphenyl ether, dipropyl ether, diisopropyl ether, di-«-butyl ether, diisobutyl ether, diisoamyl ether, ethylene glycol dimethyl ether, isopropyl ethyl ether, tetrahydrofuran, dioxane, dichlorodiethyl ether and polyethers of ethylene oxide and/or propylene oxide; nitrocarbons such as nitromethane, nitroethane, nitropro- pane, nitrobenzene, chloronitrobenzene, o-nitrotoluene; nitriles such as acetonitrile, methylnitrile, propionitrile, butyronitrile, isobutyronitrile, benzonitrile, phenylnitrile, m-chlorobenzonitrile, and also compounds such as tetrahydrothiophene dioxide and dimethyl sulphoxide, tetramethylene sulphoxide, dipropyl sulphoxide, benzyl methyl sulphoxide, diisobutyl sulphoxide, dibutyl sulphoxide, diisoamyl sulphoxide; sulphones such as dimethyl, diethyl, dipropyl, dibutyl, diphenyl, dihexyl, methylethyl, ethylpropyl, ethylisobutyl and pentamethyl- ene sulphone; aliphatic, cycloaliphatic or aromatic hydrocarbons such as pentane, hexane, heptane, octane, nonane and technical-grade hydrocarbons, for example so-called white spirits with components having boiling points in the range for example from 40°C to 250°C, cymene, benzine fractions within a boiling interval from 70°C to 190°C, cyclohexane, methylcyclohexane, petroleum ether, ligroin, octane, benzene, toluene, nitrobenzene and xylene. Of the aforementioned solvents, particular preference is given xylene, cyclohexane and tolu- ene.
In a further embodiment, the reaction between amine and the carbonyl compound of the formula (III) can also take place without a diluent.
If process (B) is carried out in a solvent, the solvent can be removed by distillation after the end of the reaction. This can take place under atmospheric pressure or reduced pressure at room temperature or elevated tempera- tures. However, the mixture can also be transferred directly to the hydrogenation, which is advantageous particularly from the point of view of economic considerations. In this embodiment of the process according to the invention, a work-up of the imine of the formula (I) is then dispensed with.
Moreover, the present invention further provides the N-[(aryl)methylene]cyclopropanamine derivative of the general formula (I)
Figure imgf000008_0001
in which Z, X and n have the meanings given above,
which are used as intermediates in the preparation of the N-(benzyl)cyclopropanamines of the general formula (II). The present invention is illustrated by reference to the examples below, although he examples should not be interpreted in a manner which limits the invention.
Preparation Examples:
General working instructions:
1.03 molar equivalents of cyclopropylamine are added dropwise to 1 equivalent of the aldehyde [carbonyl compound of the formula (III) in which Z is hydrogen] - a 1.80 molar solution in methanol - and stirred for one hour at room temperature. 0.09 mol% of a palladium catalyst on activated carbon are then added. After rendering the autoclave inert with nitrogen, 6 bar of hydrogen are injected and the reaction mixture is stirred at room temperature until the hydrogen absorption has finished. The catalyst is separated off by filtration and the sol- vent is removed by distillation.
Example 1 : Synthesis of N-(3-fluorobenzyl)cvclopropanamine
Figure imgf000009_0001
The reaction was carried out on a 0.072 molar scale. The hydrogen absorption was complete after five hours. The desired product was obtained in 91.8% yield.
^-NMR (CDC13): 7.29 - 7.25 (m, 1H), 7.08 (d, 1H), 7.03 (dt, 1H), 6.93 (t, 1H), 3.82 (s, 2H), 2.14 (m, 1H), 2.01 (br s, 1H), 0.46 - 0.37 (m, 4H).
Example 2: Synthesis of methyl 4-r(cvclopropylamino)methyllbenzoate
Figure imgf000009_0002
The reaction was carried out on a 0.072 molar scale. The hydrogen absorption was complete after five hours. The desired product was obtained in 80.4% yield.
^-NMR (CDCI3): 7.99 (d, 2H), 7.38 (d, 2H), 3.90 (s, 3H), 3.89 (s, 2H), 2.40 (br s, 1H), 2.20 - 2.12 (m, 1H), 0.46 - 0.37 (m, 4H).
Example 3: Synthesis of N-(l-naphthylmethyl)cvclopropanamine
Figure imgf000009_0003
The reaction was carried out on a 0.072 molar scale. The hydrogen absorption was complete after nine hours. The desired product was obtained in 80.4% yield. ^-NMR (CDCI3): 8.11 (d, 1H), 7.85 (dd, 1H), 7.75 (d, 1H), 7.54 - 7.40 (m, 4H), 4.29 (s, 2H), 1.93 (br s, 1H), 2.22 (m, 1H), 0.49 - 0.44 (m, 4H).
Figure imgf000010_0001
The reaction was carried out on a 0.129 molar scale. The hydrogen absorption was complete after four hours. The desired product was obtained in 91.9% yield.
TT-NMR (CD3CN): 7.29 (dd, 1H), 7.25 (dd, 1H), 7.22 - 7.19 (m, 1H), 7.12 - 7.09 (m, 1H), 3.82 (s, 2H), 3.32-3.29 (m, 1H), 2.15-2.12 (m,lH), 1.93 (br s, 1H), 1.20 (d, 6H), 0.40 - 0.38 (m, 2H), 0.28 - 0.27 (m, 2H).
Example 5: Synthesis of N-(4-methylbenzyl)cvclopropanamine
Figure imgf000010_0002
The reaction was carried out on a 0.073 molar scale. The hydrogen absorption was complete after seven hours. The desired product was obtained in 83.3% yield.
^-NMR (CDCI3): 7.18 (d, 2H), 7.11 (d, 2H), 3.78 (s, 2H), 2.32 (s, 3H), 2.14 - 2.10 (m, 1H), 1.85 (br s, 1H), 0.44 - 0.36 (m, 4H). Example 6: Synthesis of N-(4-tert-butylbenzyl)cvclopropanamine
Figure imgf000010_0003
The reaction was carried out on a 0.049 molar scale. The hydrogen absorption was complete after three hours. The desired product was obtained in 90.8% yield.
^-NMR (CDCI3): 7.33 (d, 2H), 7.24 (d, 2H), 3.82 (s, 2H), 3.15 (br s, 1H), 2.19 - 2.15 (m, 1H), 1.30 (s, 9H), 0.45 - 0.42 (m, 4H).
Example 7: Synthesis of N-(4-methoxybenzyl)cvclopropanamine
Figure imgf000010_0004
The reaction was carried out on a 0.072 molar scale. The hydrogen absorption was complete after six hours. The desired product was obtained in 88.6% yield. ^-NMR (CDCI3): 7.21 (d, 2H), 6.85 (d, 2H), 3.78 (s, 3H), 3.76 (s, 2H), 2.14 2.10 (m, 1H), 1.78 (br s, 0.44 - 0.36 (m, 4H).
Example 8: Synthesis of N-(2.4-dimethylbenzyl)cvclopropanamine
Figure imgf000011_0001
The reaction was carried out on a 0.037 molar scale. The hydrogen absorption was complete after two hours. The desired product was obtained in 88.6% yield.
^-NMR (CDCI3): 7.13 (d, 1H), 6.96 (s, 1H), 6.95 (s, 1H), 3.79 (s, 2H), 2.31 (s, 4H, CH3+NH), 2.28 (s, 3H), 2.17 - 2.14 (m, 1H), 0.45 - 0.39 (m, 4H).
Example 9: Synthesis of N.N'-rbenzene-1.4-diylbis(methylene)ldicvclopropanamine
Figure imgf000011_0002
The reaction was carried out on a 0.037 molar scale. As a departure from the general working instruction, 2.06 equivalents of cyclopropylamine were added, based on the terephthalaldehyde. The hydrogen absorption was complete after 14 hours. The product was obtained in 88.1% yield.
TT-NMR (CDC13): 7.20 (d, 2H), 7.13 (d, 2H), 3.82 (s, 4H), 2.15-2.12 (m, 2H), 1.79 (br s, 2H), 0.44 - 0.37 (m, 8H).

Claims

Patent Claims
Process s of the general formula (II)
Figure imgf000012_0001
in which
Z is hydrogen, Ci-Cg-alkyl, Ci-C4-haloalkyl or C3-C7-cycloalkyl,
X is halogen, cyano, hydroxyl, Ci-Cg-alkyl, Ci-Cg-haloalkyl having up to 9 identical or different halogen atoms, Ci-Cg-alkylamino, di(Ci-Cg-alkyl)amino, Ci-Cg-alkoxy, Ci-Cg-haloalkoxy having up to 9 identical or different halogen atoms, Ci-Cg-alkoxy-Ci-Cg-alkyl; Ci-Cg-alkylsulphanyl, Ci-C8- haloalkylsulphanyl having up to 9 identical or different halogen atoms, C3-C7-cycloalkyl, (C3-C7- cycloalkyl)-Ci-Cg-alkyl, C3-C7-halocycloalkyl having up to 9 identical or different halogen atom, formyl, formyloxy, formylamino, carboxy, carbamoyl, N-hydroxycarbamoyl, carbamates, (Ci-C8- alkyl)carbonyl, (Ci-Cg-haloalkyl)carbonyl having up to 9 identical or different halogen atoms, Q- Cg-alkylcarbamoyl, di(Ci-Cg-alkyl)carbamoyl, N-(Ci-C8-alkyloxy)carbamoyl, (Ci-Cg-alkoxy)- carbamoyl, N-Ci-C8-alkyl-(Ci-C8-alkoxy)carbamoyl, (Ci-C8-alkoxy)carbonyl, (Ci-Cg-haloalk- oxy)carbonyl having up to 9 identical or different halogen atoms, (Ci-Cg-akylamino)carbonyl, di- (Ci-Cg-alkylamino)carbonyl, (Ci-C8-alkyl)carbonyloxy, (Ci-Cg-haloalkyl)carbonyloxy having up to 9 identical or different halogen atoms, (Ci-Cg-alkyl)carbonylamino, (Ci-Cg-haloalkyl)carbonyl- amino having up to 9 identical or different halogen atoms, (Ci-Cg-alkylamino)carbonyloxy, di-(Ci- Cg-alkylamino)carbonyloxy, (Ci-C8-alkyloxy)carbonyloxy, Ci-C8-alkylsulphenyl, Ci-C8- haloalkylsulphenyl having up to 9 identical or different halogen atoms, Ci-C8-alkylsulphinyl, Ci-C8- haloalkylsulphinyl having up to 9 identical or different halogen atoms, Ci-C8-alkylsulphonyl, Ci-C8- haloalkylsulphonyl having up to 9 identical or different halogen atoms, tri(Ci-C8-alkyl)silyl, tri(Ci- C8-alkyl)silyl-Ci-C8-alkyl,
moreover two substituents X can form a 5- or 6-membered ring, which may be saturated or unsaturated and optionally also comprises heteroatoms,
n is 1, 2, 3, 4 or 5,
characte derivatives of the general formula (I)
Figure imgf000012_0002
in which Z, X and n have the meanings given above,
are catalytically hydrogenated.
2. Process according to Claim 1, characterized in that the hydrogenation catalyst used is precious metal catalysts, such as ruthenium catalysts, palladium catalysts, platinum catalysts and rhodium catalysts, Raney nickel catalysts, Raney cobalt and Lindlar catalysts or the Wilkinson catalyst, where the catalysts can also be used in supported form applied to carbon (carbon or activated carbon), aluminium oxide, silicon dioxide, zirconium dioxide, calcium carbonate or titanium dioxide.
3. Process according to Claim 1 or 2, characterized in that the catalyst, based on the imine of the formula (I) used, is used in a concentration of about 0.01 to about 30% by weight.
4. Use of N es of the general formula (I)
Figure imgf000013_0001
in which
Z is hydrogen, Ci-Cg-alkyl, Ci-C4-haloalkyl or C3-C7-cycloalkyl,
X is halogen, cyano, hydroxyl, Ci-Cg-alkyl, Ci-Cg-haloalkyl having up to 9 identical or different halogen atoms, Ci-Cg-alkylamino, di(Ci-Cg-alkyl)amino, Ci-Cg-alkoxy, Ci-Cg-haloalkoxy having up to 9 identical or different halogen atoms, Ci-Cg-alkoxy-Ci-Cg-alkyl; Ci-Cg-alkylsulphanyl, Q-Cg- haloalkylsulphanyl having up to 9 identical or different halogen atoms, C3-C7-cycloalkyl, (C3-C7- cycloalkyl)-Ci-Cg-alkyl, C3-C7-halocycloalkyl having up to 9 identical or different halogen atom, formyl, formyloxy, formylamino, carboxy, carbamoyl, N-hydroxycarbamoyl, carbamates, (Q-Cg- alkyl)carbonyl, (Ci-Cg-haloalkyl)carbonyl having up to 9 identical or different halogen atoms, Q- Cg-alkylcarbamoyl, di(Ci-Cg-alkyl)carbamoyl, N-(Ci-Cg-alkyloxy)carbamoyl, (Q-Cg- alkoxy)carbamoyl, N-Ci-Cg-alkyl-(Ci-Cg-alkoxy)carbamoyl, (Ci-C8-alkoxy)carbonyl, (Q-Cg- haloalkoxy)carbonyl having up to 9 identical or different halogen atoms, (Ci-Cg-akylamino)- carbonyl, di(Ci-Cg-alkylamino)carbonyl, (Ci-Cg-alkyl)carbonyloxy, (Ci-Cg-haloalkyl)carbonyloxy having up to 9 identical or different halogen atoms, (Ci-Cg-alkyl)carbonylamino, (Ci-Cg-haloalkyl)- carbonylamino having up to 9 identical or different halogen atoms, (Ci-Cg-alkylamino)carbonyloxy, di-(Ci-Cg-alkylamino)carbonyloxy, (Ci-Cg-alkyloxy)carbonyloxy, Ci-Cg-alkylsulphenyl, Q-Cg- haloalkylsulphenyl having up to 9 identical or different halogen atoms, Ci-Cg-alkylsulphinyl, Q-Cg- haloalkylsulphinyl having up to 9 identical or different halogen atoms, Ci-Cg-alkylsulphonyl, Q-Cg- haloalkylsulphonyl having up to 9 identical or different halogen atoms, tri(Ci-Cg-alkyl)silyl, tri(Ci- Cg-alkyl)silyl-Ci-Cg-alkyl,
moreover two substituents X can form a 5- or 6-membered ring, which may be saturated or unsaturated and optionally also comprises heteroatoms,
n is 1, 2, 3, 4 or 5,
for the preparation of N-(benzyl)cyclopropanamines of the general formula (II) in which Z, X and n have the meanings given above.
5. Process for the preparation of the N-[(aryl)methylene]cyclopropanamine derivatives of the general formula (I)
Figure imgf000014_0001
in which
Z is hydrogen, Ci-Cg-alkyl, Ci-C4-haloalkyl or C3-C7-cycloalkyl,
X is halogen, cyano, hydroxyl, Ci-Cg-alkyl, Ci-Cg-haloalkyl having up to 9 identical or different halogen atoms, Ci-Cg-alkylamino, di(Ci-Cg-alkyl)amino, Ci-Cg-alkoxy, Ci-Cg-haloalkoxy having up to 9 identical or different halogen atoms, Ci-Cg-alkoxy-Ci-Cg-alkyl; Ci-Cg-alkylsulphanyl, Ci-C8- haloalkylsulphanyl having up to 9 identical or different halogen atoms, C3-C7-cycloalkyl, (C3-C7- cycloalkyl)-Ci-Cg-alkyl, C3-C7-halocycloalkyl having up to 9 identical or different halogen atom, formyl, formyloxy, formylamino, carboxy, carbamoyl, N-hydroxycarbamoyl, carbamates, (Ci-C8- alkyl)carbonyl, (Ci-Cg-haloalkyl)carbonyl having up to 9 identical or different halogen atoms, Q- Cg-alkylcarbamoyl, di(Ci-Cg-alkyl)carbamoyl, N-(Ci-Cg-alkyloxy)carbamoyl, (Ci-Cg-alk- oxy)carbamoyl, N-Ci-Cg-alkyl-(Ci-C8-alkoxy)carbamoyl, (Ci-C8-alkoxy)carbonyl, (Ci-Cg-halo- alkoxy)carbonyl having up to 9 identical or different halogen atoms, (Ci-Cg-akylamino)carbonyl, di(Ci-Cg-alkylamino)carbonyl, (Ci-C8-alkyl)carbonyloxy, (Ci-Cg-haloalkyl)carbonyloxy having up to 9 identical or different halogen atoms, (Ci-Cg-alkyl)carbonylamino, (Ci-Cg-haloalkyl)carbonyl- amino having up to 9 identical or different halogen atoms, (Ci-Cg-alkylamino)carbonyloxy, di-(Ci- Cg-alkylamino)carbonyloxy, (Ci-Cg-alkyloxy)carbonyloxy, Ci-Cg-alkylsulphenyl, Q-Cg- haloalkylsulphenyl having up to 9 identical or different halogen atoms, Ci-Cg-alkylsulphinyl, Ci-C8- haloalkylsulphinyl having up to 9 identical or different halogen atoms, Ci-Cg-alkylsulphonyl, Ci-C8- haloalkylsulphonyl having up to 9 identical or different halogen atoms, tri(Ci-Cg-alkyl)silyl, tri(Ci- Cg-alkyl)silyl-Ci-Cg-alkyl,
moreover two substituents X can form a 5- or 6-membered ring, which may be saturated or unsaturated and optionally also comprises heteroatoms,
n is 1, 2, 3, 4 or 5,
characterized in that cyclopropylamine is condensed with carbonyl compounds of the general formula (III)
Figure imgf000015_0001
in which Z, X and n have the meanings given above.
Process s of the general formula (II)
Figure imgf000015_0002
in which
Z is hydrogen, Ci-Cg-alkyl, Ci-C4-haloalkyl or C3-C7-cycloalkyl,
X is halogen, cyano, hydroxyl, Ci-Cg-alkyl, Ci-Cg-haloalkyl having up to 9 identical or different halogen atoms, Ci-Cg-alkylamino, di(Ci-Cg-alkyl)amino, Ci-Cg-alkoxy, Ci-Cg-haloalkoxy having up to 9 identical or different halogen atoms, Ci-Cg-alkoxy-Ci-Cg-alkyl; Ci-Cg-alkylsulphanyl, Ci-C8- haloalkylsulphanyl having up to 9 identical or different halogen atoms, C3-C7-cycloalkyl, (C3-C7- cycloalkyl)-Ci-Cg-alkyl, C3-C7-halocycloalkyl having up to 9 identical or different halogen atom, formyl, formyloxy, formylamino, carboxy, carbamoyl, N-hydroxycarbamoyl, carbamates, (Ci-C8- alkyl)carbonyl, (Ci-Cg-haloalkyl)carbonyl having up to 9 identical or different halogen atoms, Q- Cg-alkylcarbamoyl, di(Ci-Cg-alkyl)carbamoyl, N-(Ci-Cg-alkyloxy)carbamoyl, (Ci-Cg-alkoxy)- carbamoyl, N-Ci-Cg-alkyl-(Ci-C8-alkoxy)carbamoyl, (Ci-C8-alkoxy)carbonyl, (Ci-Cg-halo- alkoxy)carbonyl having up to 9 identical or different halogen atoms, (Ci-Cg-akylamino)carbonyl, di(Ci-Cg-alkylamino)carbonyl, (Ci-C8-alkyl)carbonyloxy, (Ci-Cg-haloalkyl)carbonyloxy having up to 9 identical or different halogen atoms, (Ci-Cg-alkyl)carbonylamino, (Ci-Cg-haloalkyl)carbonyl- amino having up to 9 identical or different halogen atoms, (Ci-Cg-alkylamino)carbonyloxy, di-(Ci- Cg-alkylamino)carbonyloxy, (Ci-Cg-alkyloxy)carbonyloxy, Ci-Cg-alkylsulphenyl, Ci-Cg-halo- alkylsulphenyl having up to 9 identical or different halogen atoms, Ci-Cg-alkylsulphinyl, Ci-C8- haloalkylsulphinyl having up to 9 identical or different halogen atoms, Ci-Cg-alkylsulphonyl, Ci-C8- haloalkylsulphonyl having up to 9 identical or different halogen atoms, tri(Ci-Cg-alkyl)silyl, tri(Ci- Cg-alkyl)silyl-Ci-Cg-alkyl,
moreover two substituents X can form a 5- or 6-membered ring, which may be saturated or unsaturated and optionally also comprises heteroatoms,
n is 1, 2, 3, 4 or 5,
characterized in that, in a first step [process (B)], cyclopropylamine is condensed with carbonyl compounds of the general formula (III) in which Z, X und n have the meanings given above,
and the resulting N-[(aryl)methylene]cyclopropanamine derivatives of the general formula (I)
Figure imgf000016_0001
in which Z, X and n have the meanings given above,
are catalytically hydrogenated in a second step [process (A)].
7. N- the general formula (I)
Figure imgf000016_0002
in which
Z is hydrogen, Ci-Cg-alkyl, Ci-C4-haloalkyl or C3-C7-cycloalkyl,
X is halogen, cyano, hydroxyl, Ci-Cg-alkyl, Ci-Cg-haloalkyl having up to 9 identical or different halogen atoms, Ci-Cg-alkylamino, di(Ci-Cg-alkyl)amino, Ci-Cg-alkoxy, Ci-Cg-haloalkoxy having up to 9 identical or different halogen atoms, Ci-Cg-alkoxy-Ci-Cg-alkyl; Ci-Cg-alkylsulphanyl, Ci-C8- haloalkylsulphanyl having up to 9 identical or different halogen atoms, C3-C7-cycloalkyl, (C3-C7- cycloalkyl)-Ci-Cg-alkyl, C3-C7-halocycloalkyl having up to 9 identical or different halogen atom, formyl, formyloxy, formylamino, carboxy, carbamoyl, N-hydroxycarbamoyl, carbamates, (Ci-C8- alkyl)carbonyl, (Ci-Cg-haloalkyl)carbonyl having up to 9 identical or different halogen atoms, Q- Cg-alkylcarbamoyl, di(Ci-Cg-alkyl)carbamoyl, N-(Ci-Cg-alkyloxy)carbamoyl, (Ci-Cg-alk- oxy)carbamoyl, N-Ci-Cg-alkyl-(Ci-Cg-alkoxy)carbamoyl, (Ci-C8-alkoxy)carbonyl, (Ci-Cg-halo- alkoxy)carbonyl having up to 9 identical or different halogen atoms, (Ci-Cg-akylamino)carbonyl, di(Ci-Cg-alkylamino)carbonyl, (Ci-C8-alkyl)carbonyloxy, (Ci-Cg-haloalkyl)carbonyloxy having up to 9 identical or different halogen atoms, (Ci-Cg-alkyl)carbonylamino, (Ci-Cg-haloalkyl)carbonyl- amino having up to 9 identical or different halogen atoms, (Ci-Cg-alkylamino)carbonyloxy, di-(Ci- Cg-alkylamino)carbonyloxy, (Ci-Cg-alkyloxy)carbonyloxy, Ci-Cg-alkylsulphenyl, Q-Cg- haloalkylsulphenyl having up to 9 identical or different halogen atoms, Ci-Cg-alkylsulphinyl, Ci-C8- haloalkylsulphinyl having up to 9 identical or different halogen atoms, Ci-Cg-alkylsulphonyl, Ci-C8- haloalkylsulphonyl having up to 9 identical or different halogen atoms, tri(Ci-Cg-alkyl)silyl, tri(Ci- Cg-alkyl)silyl-Ci-Cg-alkyl, moreover two substituents X can form a 5- or 6-membered ring, which may be saturated or unsaturated and optionally also comprises heteroatoms,
n is 1, 2, 3, 4 or 5.
PCT/EP2011/069426 2010-11-05 2011-11-04 Process for the preparation of substituted n-(benzyl)cyclopropanamines by imine hydrogenation WO2012059585A1 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
KR1020137014336A KR101874659B1 (en) 2010-11-05 2011-11-04 Process for the preparation of substituted n-(benzyl)cyclopropanamines by imine hydrogenation
MX2015006719A MX364906B (en) 2010-11-05 2011-11-04 Process for the preparation of substituted n-(benzyl)cyclopropana mines by imine hydrogenation.
US13/883,241 US9260378B2 (en) 2010-11-05 2011-11-04 Process for the preparation of substituted N-(benzyl)cyclopropanamines by imine hydrogenation
MX2013004881A MX2013004881A (en) 2010-11-05 2011-11-04 Process for the preparation of substituted n-(benzyl)cyclopropana mines by imine hydrogenation.
EP11778894.3A EP2635551B1 (en) 2010-11-05 2011-11-04 Process for the preparation of substituted n-(benzyl)cyclopropanamines by imine hydrogenation
JP2013537149A JP2014503481A (en) 2010-11-05 2011-11-04 Process for the preparation of substituted N- (benzyl) cyclopropanamine by imine hydrogenation
ES11778894.3T ES2680546T3 (en) 2010-11-05 2011-11-04 Preparation procedure of N- (benzyl) cyclopropanamines substituted by imine hydrogenation
DK11778894.3T DK2635551T3 (en) 2010-11-05 2011-11-04 PROCEDURE FOR THE PREPARATION OF SUBSTITUTED N- (BENZYL) CYCLOPROPANAMINES USING IMINHYDRATION
CN201180053177.2A CN103402970B (en) 2010-11-05 2011-11-04 Process for the preparation of substituted n-(benzyl)cyclopropanamines by imine hydrogenation
BR112013010990-4A BR112013010990B1 (en) 2010-11-05 2011-11-04 PROCESS FOR THE PREPARATION OF N- (BENZYL) CYCLOPROPANAMINES, PROCESS FOR PREPARATION OF N - [(ARYL) METHYLENE] CICLOPROPANAMINE AND N - [(ARYL) METHYLENE] CICLOPROPANAMINE
IL226132A IL226132B (en) 2010-11-05 2013-05-02 Process for the preparation of substituted n-(benzyl) cyclopropanamines by imine hydrogenation

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US41051710P 2010-11-05 2010-11-05
EP10190077 2010-11-05
US61/410,517 2010-11-05
EP10190077.7 2010-11-05

Publications (1)

Publication Number Publication Date
WO2012059585A1 true WO2012059585A1 (en) 2012-05-10

Family

ID=43805674

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2011/069426 WO2012059585A1 (en) 2010-11-05 2011-11-04 Process for the preparation of substituted n-(benzyl)cyclopropanamines by imine hydrogenation

Country Status (12)

Country Link
US (1) US9260378B2 (en)
EP (1) EP2635551B1 (en)
JP (1) JP2014503481A (en)
KR (1) KR101874659B1 (en)
CN (1) CN103402970B (en)
BR (1) BR112013010990B1 (en)
DK (1) DK2635551T3 (en)
ES (1) ES2680546T3 (en)
IL (1) IL226132B (en)
MX (1) MX2013004881A (en)
TW (2) TWI562977B (en)
WO (1) WO2012059585A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9440908B2 (en) 2012-04-26 2016-09-13 Bayer Cropscience Ag Process for preparing N-(5-chloro-2-isopropylbenzyl)cyclopropanamine

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2016143737A1 (en) * 2015-03-11 2017-12-28 三菱瓦斯化学株式会社 NOVEL POLYAMINE COMPOUND AND PROCESS FOR PRODUCING THE SAME, AND EPOXY RESIN CURANT, EPOXY RESIN COMPOSITION, AND EPOXY RESIN CURED PRODUCT USING THE SAME
US9958781B2 (en) * 2015-04-24 2018-05-01 Jsr Corporation Method for film formation, and pattern-forming method

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006066896A2 (en) 2004-12-23 2006-06-29 Novartis Ag Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin
WO2007087906A1 (en) 2006-02-01 2007-08-09 Bayer Cropscience Sa Fungicide n-cycloalkyl-benzyl-amide derivatives
WO2008033456A1 (en) * 2006-09-15 2008-03-20 Schering Corporation Spiro-condensed azetidine derivatives useful in treating pain, diabetes and disorders of lipid metabilism
EP2119703A1 (en) * 2007-01-15 2009-11-18 Santen Pharmaceutical Co., Ltd Novel indole derivative having inhibitory activity on i b kinase

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3083226A (en) * 1961-10-18 1963-03-26 Abbott Lab N-benzyl cyclopropylamines and carbamates
US3153093A (en) * 1961-11-22 1964-10-13 Abbott Lab Amino derivatives of nu-cyclopropylbenzylamines
US6252090B1 (en) * 2000-08-29 2001-06-26 Allergan Sales, Inc. Compounds having activity as inhibitors of cytochrome P450RAI
ATE496884T1 (en) * 2002-10-11 2011-02-15 Actelion Pharmaceuticals Ltd SULPHONYLAMINOACETIC ACID DERIVATIVES AND THEIR USE AS OREXIN RECEPTOR ANTAGONISTS
CA2663502A1 (en) 2006-09-15 2008-03-20 Schering Corporation Azetidinone derivatives and methods of use thereof
EP3150589A1 (en) * 2007-06-08 2017-04-05 MannKind Corporation Ire-1a inhibitors
WO2009135299A1 (en) * 2008-05-05 2009-11-12 Merck Frosst Canada Ltd. 3, 4 - substituted piperidine derivatives as renin inhibitors
WO2013160387A1 (en) * 2012-04-26 2013-10-31 Bayer Cropscience Ag Process for preparing n-(5-chloro-2-isopropylbenzyl)cyclopropanamine

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006066896A2 (en) 2004-12-23 2006-06-29 Novartis Ag Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin
WO2007087906A1 (en) 2006-02-01 2007-08-09 Bayer Cropscience Sa Fungicide n-cycloalkyl-benzyl-amide derivatives
WO2008033456A1 (en) * 2006-09-15 2008-03-20 Schering Corporation Spiro-condensed azetidine derivatives useful in treating pain, diabetes and disorders of lipid metabilism
EP2119703A1 (en) * 2007-01-15 2009-11-18 Santen Pharmaceutical Co., Ltd Novel indole derivative having inhibitory activity on i b kinase

Non-Patent Citations (16)

* Cited by examiner, † Cited by third party
Title
A. D. DILMAN ET AL: "Trifluoromethylation of salicyl aldimines", JOURNAL OF ORGANIC CHEMISTRY., vol. 72, no. 22, 2007, USAMERICAN CHEMICAL SOCIETY, WASHINGTON, DC., pages 8604 - 8607, XP002631590, ISSN: 0022-3263 *
BIOORG. MED CHEM., vol. 14, 2006, pages 8506 - 8518
BOWMAN W R ET AL: "GENERATION OF AMINYL RADICALS USING SULFENAMIDES AS SYNTHETIC PRECURSORS", TETRAHEDRON, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 50, no. 4, 1 January 1994 (1994-01-01), pages 1275 - 1294, XP002046441, ISSN: 0040-4020, DOI: DOI:10.1016/S0040-4020(01)80837-1 *
CHEM. EUR. J, vol. 3, 1997, pages 1370 - 1374
H. T. NAGASAWA ET AL: "Latent inhibitors of aldehyde dehydrogenase as alcohol deterrent agents", JOURNAL OF MEDICINAL CHEMISTRY., vol. 27, no. 10, 1984, USAMERICAN CHEMICAL SOCIETY. WASHINGTON., pages 1335 - 1339, XP002631589, ISSN: 0022-2623 *
HARADA, THE CHEMISTRY OF THE CARBON-NITROGEN DOUBLE BOND, pages 276 - 293
J LAB. COMP. RADIOPHARM., vol. 18, 1981, pages 781 - 90
J ORG. CHEM., vol. 65, 2000, pages 96 - 103
K. VUKICS ET AL: "Synthesis of C-aryl-N-cyclopropylnitrones", SYNTHETIC COMMUNICATIONS., vol. 33, no. 19, 2003, TAYLOR & FRANCIS GROUP, pages 3419 - 3425, XP002631591, ISSN: 0039-7911 *
NISHIMURA: "Handbook of Heterogeneous Catalytic Hydrogenation for Organic Synthesis", 2001, JOHN WILEY & SONS, pages: 640 - 647
NISHIMURA: "Handbook of Heterogeneous Catalytic Hydrogenation for Organic Synthesis2", 2001, JOHN WILEY AND SONS, pages: 226 - 250
RYLANDER: "Catalytic Hydrogenation in Organic Syntheses", 1979, ACADEMIC PRESS, pages: 251 - 259
RYLANDER: "Catalytic Hydrogenation over Platinum Metals", 1967, ACADEMIC PRESS, pages: 291 - 303
SYNTHETIC COMMUN., vol. 33, 2003, pages 3419 - 3425
TETRAHEDRON, vol. 64, 2008, pages 11783 - 11788
TRIPATHI R P ET AL: "Synthesis and antitubercular activity of substituted phenylmethyl- and pyridylmethyl amines", BIOORGANIC & MEDICINAL CHEMISTRY, PERGAMON, GB, vol. 14, no. 24, 15 December 2006 (2006-12-15), pages 8186 - 8196, XP025133654, ISSN: 0968-0896, [retrieved on 20061215], DOI: DOI:10.1016/J.BMC.2006.09.020 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9440908B2 (en) 2012-04-26 2016-09-13 Bayer Cropscience Ag Process for preparing N-(5-chloro-2-isopropylbenzyl)cyclopropanamine

Also Published As

Publication number Publication date
CN103402970B (en) 2017-02-15
DK2635551T3 (en) 2018-08-06
JP2014503481A (en) 2014-02-13
TWI622573B (en) 2018-05-01
KR20130115290A (en) 2013-10-21
BR112013010990B1 (en) 2019-03-26
EP2635551A1 (en) 2013-09-11
TWI562977B (en) 2016-12-21
US9260378B2 (en) 2016-02-16
KR101874659B1 (en) 2018-07-04
IL226132B (en) 2018-02-28
US20130217910A1 (en) 2013-08-22
TW201700451A (en) 2017-01-01
TW201249780A (en) 2012-12-16
EP2635551B1 (en) 2018-05-02
CN103402970A (en) 2013-11-20
BR112013010990A2 (en) 2016-08-30
IL226132A0 (en) 2013-06-27
MX2013004881A (en) 2013-07-02
ES2680546T3 (en) 2018-09-10

Similar Documents

Publication Publication Date Title
EP1606242B1 (en) Azide free process for preparing 1,2-diamino compounds
HU229957B1 (en) Process for producing(s)-3-(aminomethyl)-5-methylhexanoic acid by resolving (+-)-3-(aminomethyl)-5-methylhexanoic acid
EP2606029B1 (en) Process for making tertiary aminoalcohol compounds
JP4733129B2 (en) Method for the synthesis of terbinafine and its derivatives
US9260378B2 (en) Process for the preparation of substituted N-(benzyl)cyclopropanamines by imine hydrogenation
SK80399A3 (en) Asymmetric synthesis of benzoxazinones
US8242311B2 (en) Process for preparing 2,2-difluoroethylamine and salts thereof proceeding from difluoroacetonitrile
WO2007105793A1 (en) Method for nitrating isourea
US8853449B2 (en) Process for the synthesis of agomelatine
US20170217865A1 (en) Process for the preparation of 1-(3,5-dichlorophenyl)-2,2,2-trifluoroethanone and derivatives thereof
TWI500596B (en) Process for the synthesis of 3,4-dimethoxybicyclo(4.2.0)octa-1,3,5-triene-7-carbonitrile, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
US20180362446A1 (en) Process for preparing biphenylamines from anilides by ruthenium catalysis
US7002038B2 (en) Method for producing 3-amino-4,4,4-trifluorocrotonic acid esters
WO2022241188A1 (en) Enantioselective synthesis of aminotropane compound
JP5581091B2 (en) 4-Cyclopentylcyclohexanone derivative and method for producing the same
KR20060059260A (en) Process for the preparation of an imine intermediate
JPH06157494A (en) Alpha-acylaminoketone derivative, its production and its utilization

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11778894

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2011778894

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: MX/A/2013/004881

Country of ref document: MX

ENP Entry into the national phase

Ref document number: 2013537149

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 226132

Country of ref document: IL

Ref document number: 13883241

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 20137014336

Country of ref document: KR

Kind code of ref document: A

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112013010990

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112013010990

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20130503